Resultats de la cerca - Ole‐Petter R. Hamnvik

  • Mostrar 1 - 11 resultats de 11
Refinar resultats
  1. 1
    Thyroid Dysfunction from Antineoplastic Agents

    Thyroid Dysfunction from Antineoplastic Agents per Ole‐Petter R. Hamnvik, P. Reed Larsen, E. Marqusee

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Leptin as a Modulator of Neuroendocrine Function in Humans

    Leptin as a Modulator of Neuroendocrine Function in Humans per Sami M. Khan, Ole‐Petter R. Hamnvik, Mary Brinkoetter, Christos S. Mantzoros

    Publicat 2012
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Associations between immune-related thyroid dysfunction and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis

    Associations between immune-related thyroid dysfunction and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis per Yee-Ming Melody Cheung, Wei Wang, Bradley A. McGregor, Ole‐Petter R. Hamnvik

    Publicat 2022
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Telemedicine and Inequities in Health Care Access: The Example of Transgender Health

    Telemedicine and Inequities in Health Care Access: The Example of Transgender Health per Ole‐Petter R. Hamnvik, Shailesh Agarwal, Christopher G. AhnAllen, Anna L. Goldman, Sari L. Reisner

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Morbidity and mortality in patients with craniopharyngioma after surgery

    Morbidity and mortality in patients with craniopharyngioma after surgery per Rachel Crowley, Ole‐Petter R. Hamnvik, E. P. O’Sullivan, LA Behan, Debbie Smith, Amar Agha, C.J. Thompson

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Leptin in human physiology and pathophysiology

    Leptin in human physiology and pathophysiology per Christos S. Mantzoros, Faidon Magkos, Mary Brinkoetter, Elizabeth Sienkiewicz, Tina A. Dardeno, Sang Yong Kim, Ole‐Petter R. Hamnvik, Anastasia Koniaris

    Publicat 2011
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway

    Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway per Ole‐Petter R. Hamnvik, Toni K. Choueiri, Alexander Turchin, Rana R. McKay, Lipika Goyal, Michael Davis, Marina D. Kaymakcalan, Jonathan S. Williams

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals

    Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals per Hyun‐Seuk Moon, Μaria Dalamaga, Sang Yong Kim, Stergios A. Pοlyzos, Ole‐Petter R. Hamnvik, Faidon Magkos, Jason Paruthi, Christos S. Mantzoros

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma

    Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma per Rana R. McKay, Gustavo E. Rodriguez, Xun Lin, Marina D. Kaymakcalan, Ole‐Petter R. Hamnvik, Venkata Sabbisetti, Rupal S. Bhatt, Ronit Simantov, Toni K. Choueiri

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy

    Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy per Maxine Sun, Toni K. Choueiri, Ole‐Petter R. Hamnvik, Mark A. Preston, Guillermo de Velasco, Wei Jiang, Stacy Loeb, Paul L. Nguyen, Quoc‐Dien Trinh

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort

    Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort per Dorothee M. Baur, Jens Klotsche, Ole‐Petter R. Hamnvik, Caroline Sievers, Lars Pieper, Hans‐Ulrich Wïttchen, Günter K. Stalla, Roland M. Schmid, Stefanos N. Kales, Christos S. Mantzoros

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: